Cited by 309Adipokines, Inflammation, and Metabolic DiseasesDiabetes Treatment and ManagementAdipose Tissue and Metabolism

Inflammatory Process in Type 2 Diabetes: The Role of Cytokines

ALEXANDRAKI, KRYSTALLENIA, PIPERI, CHRISTINA, KALOFOUTIS, CHRISTOS, SINGH, JAIPAUL, ALAVERAS, ANTONIS, KALOFOUTIS, ANASTASIOS·2006·Annals of the New York Academy of Sciences

Abstract

Abstract: Population‐based studies have shown strong relationship between inflammatory markers and metabolic disturbances, obesity, and atherosclerosis, whereas inflammation has been considered as a “common soil” between these clinical entities and type 2 diabetes (T2D). The accumulation of macrophages in adipose tissue (AT), the common origin of macrophages and adipocytes, the prevalent presence of peripheral mononuclear cells, and apoptotic β cells by themselves seem to be the sources of inflammation present in T2D, since they generate the mediators of the inflammatory processes, namely cytokines. The main cytokines involved in the pathogenesis of T2D are interleukin‐1β (IL‐1β), with an action similar to the one present in type 1 diabetes, tumor necrosis factor‐α (TNF‐α), and IL‐6, considered as the main regulators of inflammation, leptin, more recently introduced, and several others, such as monocyte chemoattractant protein‐1, resistin, adiponectin, with either deleterious or beneficial effects in diabetic pathogenesis. The characterization of these molecules targeted diabetes treatment beyond the classical interventions with lifestyle changes and pharmaceutical agents, and toward the determination of specific molecular pathways that lead to low grade chronic inflammatory state mainly due to an immune system's unbalance.

Integrity signals

Registry

Crossref · 10.1196/annals.1372.039

Cites

282 of 282 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Type 2 diabetes, obesity, and cardiovascular disease are related to a state of low-grade systemic inflammation.

    “Type 2 diabetes, obesity, and cardiovascular disease are related to a state of low-grade systemic inflammation [7, 27–29].”
  • Elevated TNF-α is not secondary to the pathological conditions associated with insulin resistance, but plays a direct pathogenic role in glucose metabolism.

    “Thus, a number of studies indicate that elevated TNF-α is not secondary to the pathological conditions associated with insulin resistance, but that TNF-α plays a direct pathogenic role in glucose metabolism [29, 40].”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
ALEXANDRAKI, K., PIPERI, C., KALOFOUTIS, C., SINGH, J., ALAVERAS, A., & KALOFOUTIS, A.
Affiliations
  • National and Kapodistrian University of Athens (GR)
  • University of Lancashire (GB)
Corresponding author
PIPERI, CHRISTINA
Venue
Annals of the New York Academy of Sciences
Publisher
Wiley
Published
2006-11
Volume
1084
Issue
1
Pages
89-117
ISSN
  • 0077-8923 (ISSN-L)
  • 1749-6632
OpenAlex
W1491280754
Cited by
309
References
281
Citations by year
2026: 7 · 2025: 9 · 2024: 21 · 2023: 13 · 2022: 11 · 2021: 16 · 2020: 12 · 2019: 11 · 2018: 19 · 2017: 15 · 2016: 17 · 2015: 14 · 2014: 22 · 2013: 20 · 2012: 14
FWCI
2.18
Type
journal article
Language
en
Open access
closed
Locations
  • Annals of the New York Academy of Sciences (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Epidemiology › Adipokines, Inflammation, and Metabolic Diseases
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
  • Health Sciences › Medicine › Physiology › Adipose Tissue and Metabolism
Keywords
type 2 diabetes, inflammation, adipose tissue macrophages, cytokines, IL-1β, TNF-α, interleukin-6, leptin, adiponectin, resistin, MCP-1, beta-cell apoptosis, obesity, atherosclerosis, low-grade inflammation, immune dysregulation
MeSH terms
Animals, Diabetes Mellitus, Experimental, Diabetes Mellitus, Type 2, Humans, Inflammation, Cytokines

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review